FDA Inspection 1243716 — Childrens Hospital Los Angeles

Childrens Hospital Los Angeles — FEI 2080796

The FDA completed an inspection of Childrens Hospital Los Angeles on Jun 5, 2024 in Glendale, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 5, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Glendale, CA (United States)

Additional Details

IRB